Mettler‑Toledo shares jump 25% as management raises 2026‑27 EPS guidance and pledges $875 million buyback

Mettler‑Toledo International (MTD) stock has risen about 25% in the past two months despite a slowdown in biotech venture funding. The company reported Q3 revenue of $1.09 billion and adjusted EPS of $12.57, and it lifted its full‑year 2026 EPS outlook to $47.70‑$47.90 and its early‑2027 outlook to $52.50‑$53.50. Management projects roughly $900 million of free cash flow this year, enough to fund an $875 million share‑repurchase program.

The company’s higher‑than‑consensus EPS guidance and sizable free‑cash‑flow‑backed buyback could sustain the share‑price rally, according to the management outlook. Analysts note that the upgraded guidance and buyback may further boost investor sentiment.

Sources